Network-1 Technologies Approves Dividend Policy

Network-1 Technologies Approves Dividend Policy

Network-1 Technologies rose 4% in Friday’s mid-morning trade after the company said its board of directors has approved the initiation of a dividend policy as part of Network-1’s ongoing commitment to increasing shareholder value and return on investment. The newly-adopted dividend policy provides for the payment of a regular semi-annual dividend of $0.05 per common share ($0.10 per common share annually) commencing in 2017. Network-1 anticipates paying the semi-annual dividends […]

Read More ˃
Valeant Pharmaceuticals Edges Up Almost 1%

Valeant Pharmaceuticals Edges Up Almost 1%

Valeant Pharmaceuticals International is up almost 1% after the company said results were positive from a Phase 3, multicenter double-blind, randomized, vehicle-controlled clinical study assessing the safety and efficacy of IDP-118 lotion in treating plaque psoriasis. Within the Phase 3 study of 215 adult subjects with moderate to severe psoriasis, IDP-118 showed statistical significance to vehicle with a treatment success rate of 45.33%. The primary endpoint of the 12-week study […]

Read More ˃
Western Digital Renews Patent Cross-License Agreement with Samsung

Western Digital Renews Patent Cross-License Agreement with Samsung

Western Digital, a provider of storage technologies and solutions, signed a definitive royalty-bearing agreement with Samsung Electronics to renew the cross-license of the two companies’ semiconductor patent portfolios. The terms of the renewed agreement are retroactive to the end date of the prior agreement, which expired on Aug. 14. The renewed agreement will run through Dec. 31, 2024. The agreement includes rights to each party’s patents broadly covering multi-level cell […]

Read More ˃
Anthera Pharmaceuticals Climbs Almost 14% After Naming New CEO

Anthera Pharmaceuticals Climbs Almost 14% After Naming New CEO

Anthera Pharmaceuticals Inc. was soaring late Tuesday after saying it has promoted J. Craig Thompson to chief executive officer at the drugmaker, replacing Paul Truex ahead of the company completing its commercialization efforts for its Sollpura pancreatic enzyme replacement product candidate. Thompson also will join the Anthera board as a director while Truex will become executive board chairman when Christopher Henny, the current board chairman, steps aside but remains a […]

Read More ˃
Stock Indexes Rise in Early Trading

Stock Indexes Rise in Early Trading

Stock indexes were higher in early Trading Monday as oil futures climb and the dollar declines. West Texas Intermediate crude, the US benchmark, was up 0.4% and Brent futures, the global standard, added 0.9%. Prices are rising on speculation that the Organization of the Petroleum Exporting Countries will cut production as promised. Still, some analysts are skeptical that all countries will follow the agreed-upon output guidelines. Members of the organization […]

Read More ˃
CBOE Holdings Touches One-Year High

CBOE Holdings Touches One-Year High

Shares of CBOE Holdings jumped 3.6%, touching their highest level of $71.98 intraday since November 2015, after the company reported Friday November monthly trading volume and average revenue per contract data set several single-day records during the month. S&P 500 Index and CBOE Volatility Index options set record volume in non-U.S. trading hours, with total combined volume of 296,472 contracts, topping the previous record of 144,983 contracts from December 2015. […]

Read More ˃